Drug Type Small molecule drug |
Synonyms YIL 870, YIL870 |
Target |
Mechanism GHSR antagonists(Ghrelin/growth hormone secretagogue receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H28ClN3O |
InChIKeyARLXUYKHWSHMLR-SFHVURJKSA-N |
CAS Registry875259-40-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | 26 Jul 2007 |